Bio-Rad Laboratories, Inc. Class A Common Stock vs PayPal Holdings, Inc. — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while PayPal Holdings, Inc. trades at $58.29 (market cap $50.47B). The key difference: PayPal Holdings, Inc. is far larger — about 5.4× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | PYPL | |
|---|---|---|
Market Cap | $9.43B | $50.47B |
Sector | Health | Financials |
52-Week High | $356.25 | $76.13 |
52-Week Low | $241.71 | $39.08 |
Enterprise Value | $9.18B | $52.62B |
Dividend Yield | — | 0.95% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →